Business Standard

Monday, December 23, 2024 | 11:39 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Russia's Sputnik V vaccine to be available in India from next week: Govt

India expecting 156 million doses of the vaccine from August to September

Sputnik V, Dr Reddy’s Laboratories, DRL, coronavirus, vaccine, covid-19
Premium

Sputnik V, a vaccine with 91.6 per cent efficacy — the highest among Covid vaccines available in India — requires a temperature range of -18°C to -22°C to remain stable

Ruchika Chitravanshi New Delhi
Sputnik V, the vaccine developed by Russia’s Gamaleya National Center Covid, will be available in India from next week, the Union ministry of health and family welfare (MoHFW) announced on Thursday.

V K Paul, member (health) of the NITI Aayog, said on Thursday while addressing the press briefing:  “I am very happy to say the limited supply that has come from Russia will start selling in India and more supplies will come in,” said Paul. 

India is expecting 156 million doses of the vaccine from August to September. 

Sputnik V, a vaccine with 91.6 per cent efficacy — the highest among Covid vaccines

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in